Individual approach in choosing second-line targeted therapy for metastatic renal cell carcinoma

Renal cell carcinoma (RCC) is one of the most common genitourinary malignancies worldwide. Approximately 25–30 % of newly diagnosed patients have metastatic RCC (mRCC), whereas in 20–30 % of cases, dissemination occurs after radical surgical treatment. The development of targeted and immunooncologic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: B. Ya. Alekseev, I. M. Shevchuk, A. D. Kaprin
Formato: Artigo
Idioma:Russo
Publicado em: ABV-press 2018-06-01
Colecção:Onkourologiâ
Assuntos:
metastatic renal cell carcinoma
targeted therapy
tyrosine kinase inhibitors
sunitinib
axitinib
Acesso em linha:https://oncourology.abvpress.ru/oncur/article/view/846
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados